FADD and TRADD expression and apoptosis in primary hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 6, Issue 2, 2000, Pages 223-227

  Sun, Bao Hua ^a   Zhao, Xi Ping ^a   Wang, Bao Ju ^a   Yang, Dong Liang ^a   Hao, Lian Jie ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN;

ADULT; AGED; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; NONHUMAN; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

EID: 0034002022     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Wyllie AH. Apoptosis and carcinognenesis. Eur J Cell Biol, 1997;73:189-197
2. Faubion WA, Gores GJ. Death receptors in liver biology and pathobiology. Hepatology, 1999;29:1-4
3. Sun BH, Yang DL, Hao LJ. Proteolytic enzyme in apoptosis signal transduction. Guowai Yixue Fenzi Shengwuxue Fence, 1999;21:1-5
4. Kidd VJ. Proteolytic activities that mediate apoptosis. Ann Rev Physiol, 1998;60:533-573
5. Jiang YP, Woronicz JD, Liu W, Goeddel DV. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science, 1999;283:543-546
6. Liang YR, Wang CF, Zhou JH, Peng XZ. Apoptosis of hepatocyte and precancerous lesion of hepatocellular carcinoma. Huaren Xiaohua Zazhi, 1998;6(Suppl 7):160-162
7. Galle PR, Krammer PH. CD95-induced apoptosis in human liver disease. Seminars in Liver Disease, 1998;18:141-151
8. Shin EC, Shin JS, Park JH, Kim JJ, Kim H, Kim SJ. Expression of Fas-related genes in human hepatocellular carcinomas. Cancer Lett, 1998;134:155-162
9. Kondo S, Ishizaka Y, Okada T, Kondo Y, Hitomi M, Tanaka Y, Haqqi T, Barnett GH, Barna BP. FADD gene therapy for malignant gliomas in vitro and in vivo. Hum Gene Ther, 1998;9:1599-1608
10. Micheau O, Solary E, Hammann A, Dimanche-Boitrel MT. Fas ligand-independent, FADD-mediated activation of the fas death pathway by anticancer drugs. J Biol Chem, 1999;274: 7987-7992
11. Pan G, Bauer JH, Haridas V, Wang S, Liu D, Yu G, Vincenz C, Aggarwal BB, Ni J, Dixit VM. Identification and functional characterization of DR6, a novel death domain-containing TNF receptor. FEBS Lett, 1998;431:351-356